Stay updated on Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial

Sign up to get notified when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website footer now displays revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T01:45:04.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The record now presents details for the completed pediatric CNS malignancy trial of nivolumab alone or with ipilimumab, including its eligibility criteria, study design, outcomes, and participating locations. It also includes publication, record-history, and study-document information.
    Difference
    83%
    Check dated 2026-11-10T23:18:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The displayed site revision changes from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:07:29.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A general NIH website-transition notice appears above the ClinicalTrials.gov page, which continues to show a 403 error instead of the study record. The footer revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:24:07.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-06T22:36:53.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with an access-denied message. This reflects that the study information is no longer accessible on the page, rather than updates to the study details themselves.
    Difference
    19%
    Check dated 2026-09-22T23:30:26.000Z thumbnail image

Stay in the know with updates to Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric CNS Malignancies Study: Nivolumab Combo Clinical Trial page.